Sfoglia per AUTORE
CELLI M
Collezione AOU Novara

  

Items : 3

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.

2024
ASL Biella
AO Alessandria
AOU Città della Salute di Torino
AOU Novara

Zucca E; Vitolo U; Pinotti G; Dore F; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Ghiggi C; Pisani F; Zanni M; Liberati AM; Annibali O; Celli M; Bruna R; Orsucci L; Cabras MG; Tani M; Tucci A; Vanazzi A; Balzarotti M; Merli F; Stathis A; Gaidano G; Sassone M; Botto B; Conconi A; Chiappella A; Ferreri AJM; et alii...

Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL. in Blood advances / Blood Adv. 2023 Aug 8;7(15):3916-3924. doi: 10.1182/bloodadvances.2023009744.

2023
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Tisi MC; Moia R; Visco C; Arcari A; Merli F; Stelitano C; Re A; Volpetti S; Zilioli VR; Pileri SA; Quaglia FM; Ferrante M; Bruna R; Di Rocco A; Chini C; Ghiggi C; Zambello R; Zanni M; Sciarra R; Celli M; Puccini B; Cencini E; Tani M; Botto B; Spina M; Ferrero S; Evangelista A; Patti C;

Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study. in British journal of haematology / Br J Haematol. 2021 Apr;193(2):386-396. doi: 10.1111/bjh.17334. Epub 2021 Feb 22.

2021
AOU Città della Salute di Torino
AOU Novara

Zaja F; Fanin R; Rodeghiero F; Carpenedo M; Giardini I; Gigliotti CL; Boggio E; Dianzani U; Crea E; Vignetti M; Paoloni F; Santoro C; Barcellini W; Celli M; Consoli U; Valeri F; Carli G; Patriarca A; Rossi E; Auteri G; Vianelli N; Volpetti S; Palandri F; Lucchini E;